Skip to main content

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 282))

Abstract

Alzheimer’s disease will be the epidemic of the twenty-first century (1,2). The generally accepted figures are that 5% of individuals of the age of 65 have severe dementia, and another 10% have moderate dementia, with 30% having developed dementia if they live to the age of 90. The recent Boston study suggested that the figures were even higher, with 3% of those age 65 to 74 having probable Alzheimer’s disease, 18.7% of those 75 to 84, and 47.2% of those over 85 having probable Alzheimer’s disease (3). About 75% of patients with a clinical diagnosis of senile dementia prove to have Alzheimer’s disease, while a number of other disorders, such as multi-infarct dementia and other neurological degenerations, underlie the remaining proportion. Alzheimer’s disease is therefore going to be the major health care burden in the coming decades, both in terms of personal and family stress and of national health care costs. It is unnecessary, therefore, to emphasize the urgent need for an understanding of the cause of the disease and its treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Katzman, R. (1983). Demography, definitions and problems, Ch. 1 in: The Neurology of Aging. (eds) Katzman, R. and Terry, R. D., David, F. A., Philadelphia.

    Google Scholar 

  2. Plum, F. (1979). Dementia: An approaching epidemic. Mature, 279: 373–373.

    Google Scholar 

  3. Evans, D. A., Funkenstein, H. H., Albert, M. S. (1989). Prevalence of Alzheimer’s disease in a community population of older persons. JAMA, 262: 2551–2556.

    Article  PubMed  CAS  Google Scholar 

  4. Bick, K., Amaducci, L., Pepen, G. (1987). The Early Story of Alzheimer’s Disease. Liviana Press, Padova.

    Google Scholar 

  5. Editorial (1987). Alzheimer’s disease and associated disorders, Vol 1, pp. 1–4.

    Article  Google Scholar 

  6. Hansen, L. A., DeTeresa, R., Davies, D. (1988). Neocortical morphometry, lesion count, and choline acetyltransf erase levels in the age spectrum of Alzheimer’s disease, Neurol.. 38: 48–54.

    CAS  Google Scholar 

  7. Schiebel, A. B. and Tomiyasu, V. (1978). Dendritic sprouting in Alzheimer’s presenile dementia. Exper. Neurol., 60:1–8.

    Article  Google Scholar 

  8. Hamos, J. E., DeGennaro, L. J., Drachman, D. A. (1989). Synaptic loss in Alzheimer’s disease and other dementias. Neurol., 39: 355–361.

    CAS  Google Scholar 

  9. Cutler, N. R., Haxby, J. V., Duara, R. (1985). Clinical history, brain metabolism and neuro-psychological function in Alzheimer’s disease, Ann. Neurol. 18: 298–309.

    Article  PubMed  CAS  Google Scholar 

  10. Coyle, J. T., Price, D. L., Delong, M. R. (1983). Alzheimer’s disease: a disorder of cortical cholinergie innervation. Science, 219: 1184–1189.

    Article  PubMed  CAS  Google Scholar 

  11. Carlson, A. (1983). Changes in neurotransmitter systems in the aging brain and in Alzheimer’s disease. Ch 13 in Alzheimer’s Disease, eds: Reisberg, B., Free Press, New York.

    Google Scholar 

  12. Davies, P. (1983). An update on the neurochemistry of Alzheimer’s disease, pp. 75–86 in: Advances in Neurology, 38 The Dementias. Eds: Mayeux, R. and Rosen, W. G., Raven Press, New York.

    Google Scholar 

  13. Francis, P. T., Palmer, A. M., Sims, N. R. (1985). Neurochemical studies of early onset Alzheimer’s disease. New Engl. J. Med., 313: 7–11.

    Article  PubMed  CAS  Google Scholar 

  14. Ferrier, I. N., Cross, A. J., Johnson, J. A. (1983). Neuropeptides in Alzheimer’s type dementia. J. Neurol. Sci., 62: 159–170.

    Article  PubMed  CAS  Google Scholar 

  15. Waters, C. (1988). Cognitive enhancing agents: Current status in the treatment of Alzheimer’s disease. Can. J. Neurol. Sci., 15: 249–256.

    PubMed  CAS  Google Scholar 

  16. Perry, G., Rizzuto, N., Autilio-Gambetti, L. (1985). Paired helical filaments from Alzheimer’s disease patients contain cytoskeletal components. Proc. Nat. Acad. Sci., 82: 3916–3920.

    Article  PubMed  CAS  Google Scholar 

  17. Grundke-Iqbal, I., Johnson, A. B., Wisniewski, H. M. (1979). Evidence that Alzheimer’s disease neurofibrillary tangles originate from neurotubules. Lancet, 1: 578–580.

    Article  PubMed  CAS  Google Scholar 

  18. Selkoe, D. J., Abraham, C. R., Podlisny, M. D. (1986). Isolation of low molecular-weight proteins from amyloid plaque fibers in Alzheimer’s disease. J. Neurochem, 46: 1820–1834.

    Article  PubMed  CAS  Google Scholar 

  19. Blessed, G., Tomlinson, B. E., Roth, M. (1968). The association between quantitative measures of dementia and of senile changes in the cerebral grey matter of elderly subjects. Brit. J. Psychiat., 114: 797–811.

    Article  PubMed  CAS  Google Scholar 

  20. Khachaturian, Z. S. (1985). Diagnosis of Alzheimer’s disease. Arch. Neurol., 42: 1097–1105.

    PubMed  CAS  Google Scholar 

  21. Crapper, D. R., Quittkat, S., Krishnan, S. S. (1980). Intranuclear aluminum content in Alzheimer’s disease, dialysis encephalopathy and experimental aluminum encephalopathy. Acta Neuropath. (Berl.), 50: 1924.

    Article  Google Scholar 

  22. O’Hare, J. A., Callaghan, N. M. (1983). Dialysisencephalopathy. Medicine, 62: 129–141.

    PubMed  Google Scholar 

  23. Crapper, D. R., Karlik, S. and De Boni, V. (1978). Aluminum and other metals in senile (Alzheimer’s) dementia, pp. 471–484, in Alzheimer’s disease: Senile dementia and related disorders. Aging (Vol. 7). Eds: Katzman, R., Terry, R. D., Bick, K. L. Raven Press, N.Y.

    Google Scholar 

  24. Schwartz, A. S., Frey, J. L., Lukas, R. J. (1988). Risk factors in Alzheimer’s disease: Is aluminum hazardous to your health? Barrow Neurol. Inst. Quart., 4: 2–8.

    Google Scholar 

  25. Perl, D. P., Gajdusek, D. C., Garruto, R. M. (1982). Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonismdementia of Guam. Science, 217: 1053–1055.

    Article  PubMed  CAS  Google Scholar 

  26. Perl, D. P. (1983). Pathologic association of aluminum in Alzheimer’s disease,) Ch 15 in: Alzheimer’s Disease. Ed: Reisberg, B., Free Press, New York.

    Google Scholar 

  27. Pendlebury, W. W., Beal, M. F., Kowall, N. W. (1988). Neuropathologic, neurochemical and immunocytochemical characteristics of aluminum-induced neurofilamentous degeneration. Neurotoxicology, 9: 503–510.

    PubMed  CAS  Google Scholar 

  28. Pendlebury, W. W., Munos-Garcia, D., Perl, D. P. (1987). Cytoskeletal pathology in neuro-degenerative diseases. In: (eds) Ehlich, Y. H., Lenox, R. H., Koraecki, E., Molecular mechanisms of neuronal responsiveness. Plenum Press, New York, pp. 427–442.

    Google Scholar 

  29. Solomon, P. R., Beal, M. F., Pendlebury, W. W. (1988). Age-related description of classical conditioning: A model system approach to memory disorders. Neuroseology of Aging, 9: 535–546.

    Article  CAS  Google Scholar 

  30. Peterson, C., Goldman, J. E. (1986). Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. Proc. Nat. Acad. Sci., 83: 2758–2762.

    Article  PubMed  CAS  Google Scholar 

  31. Tsubaki, T., Yase, Y. (eds) (1988). Amyotrophic lateral sclerosis, Excerpta Medica Int. Conf. Series 769, Amsterdam.

    Google Scholar 

  32. Spencer, P. S., Palmer, V., Ohta, M. (1988). Cycad, a suspect etiological factor for Guam ALS/PD, is associated with motor neuron disease in Irian Jaya, Indonesia and Kii peninsula, Japan, pp. 35–40. In: Tsubaki, T. and Yase, Y. (eds): Spencer, P. S., Palmer, V., Ohta, M 769, Amsterdam.

    Google Scholar 

  33. Plaitakis, A., Caroscio, J. T. (1987). Abnormal glutamate metabolism in amyotrophie lateral sclerosis. Neurol., 22: 575–579.

    CAS  Google Scholar 

  34. Martyn, C. N., Osmond, C., Wardson, J. A. (1989). Geographical relation between Alzheimer’s disease and aluminum in drinking water. Lancet, 59–62.

    Google Scholar 

  35. Editorial, The Lancet,January 14, 1989. Aluminum and Alzheimer’s disease, 82–83.

    Google Scholar 

  36. Heston, L. L., Mastri, A. R., Anderson, V. E. (1981). Dementia of the Alzheimer’s type. Arch. Gen. Psych., 38: 1085–1090.

    CAS  Google Scholar 

  37. Heston, L. L. (1983). Genetic studies of dementia, Ch 6 in The Epidemiology of Dementia. Eds: Mortimer, J. A., Schuman, L. M., Oxford Univ. Press, New York, 101–114.

    Google Scholar 

  38. Nee, L. E., Polinsky, R. J., Eldridge, R. (1983). A family with histologically confirmed Alzheimer’s disease. Arch. Neurol., 40: 203–208.

    PubMed  CAS  Google Scholar 

  39. Matsuyama, S. S. (1983). Genetic factors in dementia of the Alzheimer-type. Ch 21 in Alzheimer’s Disease. Ed: Reisberg, B., Free Press, New York, 155–160.

    Google Scholar 

  40. Farrer, L. A., O’Sullivan, D. M., Cupples, L. A. (1989). Assessment of genetic risk for Alzheimer’s disease among first degree relatives. Ann. Neurol., 25: 485–493.

    Article  PubMed  CAS  Google Scholar 

  41. Wisniewski, K. E., Wiskiewski, H. M., Wen, G. Y. (1985). Occurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome. Ann. Neurol., 17: 278–282.

    Article  PubMed  CAS  Google Scholar 

  42. Editorial (1987). Alzheimer’s Disease, Down’s syndrome and Chromosome 21. Lancet, 1: 1011–1012.

    Google Scholar 

  43. Hardy, J. (1988). Molecular biology and Alzheimer’s disease. TINS, 11: 293–294.

    PubMed  CAS  Google Scholar 

  44. Tanzi, R. E., Gusella, J. F., Watkins, P.C. (1987). Amyloid B protein gene: cDNA, mRNA distribution and genetic linkage near the Alzheimer’s locus. Science, 235: 880–884.

    Article  PubMed  CAS  Google Scholar 

  45. St. George-Hyslop, P. H., Tanzi, R. E., Polinski, R. J. (1987). The genetic defect causing familial Alzheimer’s disease maps to chromosome 21. Science, 235: 885–890.

    Article  PubMed  CAS  Google Scholar 

  46. Mann, D. M. A., Yates, P. O. (1974). Motor neuron disease. J. Neurol. Neurosurg. Psychiat., 37: 1036–1047.

    Article  Google Scholar 

  47. Mann, D. M. A., Neary, D., Yates, P.O. (1981). Alterations in the protein synthetic capability of nerve cells in Alzheimer’s disease. J. Neurosurg. Psychiat., 44: 97–105.

    Article  CAS  Google Scholar 

  48. Mann, D. M. A., Yates, P.O. (1983). Pathological basis of neuro-transmitter changes in Parkinson’s disease. Neuropath. Exp. Neurobiol., 8: 3–14.

    Article  Google Scholar 

  49. Lewis, P. N., Lukin, W. J., DeBoni, V. (1981). Changes in chromatin structure associated with Alzheimer’s disease. J. Neurochem., 37: 1193–1202.

    Article  PubMed  CAS  Google Scholar 

  50. Crapper-McLachlan, D. R., Lewis, P. N., Lukiw, W. J. (1984). Chromatin structure in dementia. Ann. Neurol., 15: 329–334.

    Article  Google Scholar 

  51. Crapper-McLachlan, D. R., Lewis, P. N. (1985). Alzheimer’s disease: errors in gene expression. Canadian J. Neurol. Sci., 12: 1–5.

    Google Scholar 

  52. Robbins, J. H. (1978). ICN-UCLA Symposia on molecular and cellular biology, Vol IX, Academie Press, 603–629.

    Google Scholar 

  53. Andrews, A. D., Carrett, S. R., Robbins, J. H. (1978). Xeroderna pigmentosum: Neurological abnormalities correlate with colony forming ability after UV-radiation. Proc. Nat. Acad. Sci., 75: 1984–1988.

    Article  PubMed  CAS  Google Scholar 

  54. Robbins, J. H., Otswka, F., Tarone, R. E. (1983). Radiosensitivity in Alzheimer’s disease and Parkinson’s disease. Lancet, 1: 468–469.

    Article  PubMed  CAS  Google Scholar 

  55. Robinson, S. H., Munzer, J. S., Tandan, R. (1987). Alzheimer’s disease cells have defective repair of alkylating agent-induced DNA damage. Ann. Neurol., 21: 250–258.

    Article  Google Scholar 

  56. Tandan, R., Robison, S. H., Bartlett, J. D. (1988). DNA damage and repair in ALS and Alzheimer’s disease lymphoid cells and monocytes. In: Amyotrophic Lateral Sclerosis. Eds: Tsubaki, T., Yase, Y., Elsevier, New York, 113–118.

    Google Scholar 

  57. Wetmur, J. G., Casals, J., Elizan, T. S. (1984). DNA binding protein, profiles in Alzheimer’s disease. J. Neurol. Sci., 66: 201–208.

    Article  PubMed  CAS  Google Scholar 

  58. Mullaart, E., Boerrigter, M. E. T., Ravid, R. (1989). Increased levels of DNA breaks in cerebral corte of Alzheimer’s disease patients. In press.

    Google Scholar 

  59. Sajdel-Sulkowska, E. M., Marotta, C. A. (1984). Alzheimer’s disease brain: Alterations in RNA levels and in a ribonuclease-inhibitor complex, Science, 225: 947–949.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Plenum Press, New York

About this chapter

Cite this chapter

Bradley, W.G. (1990). Alzheimer’s Disease: Theories of Causation. In: Zandi, T., Ham, R.J. (eds) New Directions in Understanding Dementia and Alzheimer’s Disease. Advances in Experimental Medicine and Biology, vol 282. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0665-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-0665-8_3

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-7917-4

  • Online ISBN: 978-1-4613-0665-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics